Drugs / KP-1461
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00129194 | Aug 2005 → Jun 2007 | HIV infectious disease | Koronis Pharmaceuticals | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00504452 | Jul 2007 → Sep 2008 | HIV infectious disease | Koronis Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KP-1461 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00129194 ↗ |
| Modality | Small molecule | — CHEMBL4297297 ↗ |
| Route | Oral | “Multiple Oral Doses of KP-1461” NCT00129194 ↗ |